MedTrace Logo

Blood Flow Restriction Strength Training in Professional Soccer Players

NCT04630951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-06-02

No results posted yet for this study

Summary

The aims of this clinical study are evaluated the effects of Blood Flood Restriction training on the sport performance of professional and semi-professional soccer players. The participants are twenty male professional and semi-professional soccer players who are playing at RCD Mallorca. Participants will be assigned in two different groups. Both groups develop for six weeks a strength training programs. The first group will base their training in Low Load using Blood Flow Restriction (20-50% of one maximum repetition). The second group will base their training in High Load (60-80% of one maximum repetition). This training program includes three type of exercises in each training session; back squat, single deadlift and barbell hip thrust. Before and after this program the investigators will collect sociodemographic and anthropometrics data. On top of that, the investigators will evaluate the muscle mass, the electrical activity produced by skeletal muscles, the muscle strength and the sprint ability of every participant. Before to the evaluation, the soccer players will warm-up during 15 minutes under the control of the evaluators.

Conditions

  • Resistance Training
  • Blood Pressure

Interventions

OTHER

Blood Flow Restriction Strength training with low load

Low Load (20-50% 1RM), 4 set of 30/15/15/15 repetitions, 30 seconds resting between sets.

OTHER

High Load Strength Training

High Load (60-80% 1RM) 4 sets of 8 repetitions, 2 minutes resting between sets

Sponsors & Collaborators

  • University of the Balearic Islands

    lead OTHER

Principal Investigators

  • Natalia Romero Franco · University of Balearic Islands

  • Christian Castilla López · University of Balearic Islands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04630951 on ClinicalTrials.gov